Matches in SemOpenAlex for { <https://semopenalex.org/authorship/W2790842545A5011669959> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- W2790842545A5011669959 type Authorship @default.
- W2790842545A5011669959 hasAuthor A5011669959 @default.
- W2790842545A5011669959 hasOrganization I1283582996 @default.
- W2790842545A5011669959 hasOrganization I1334819555 @default.
- W2790842545A5011669959 hasOrganization I189718659 @default.
- W2790842545A5011669959 hasOrganization I205783295 @default.
- W2790842545A5011669959 hasOrganization I4210091341 @default.
- W2790842545A5011669959 hasOrganization I4210109986 @default.
- W2790842545A5011669959 hasOrganization I47396830 @default.
- W2790842545A5011669959 isCorresponding "false" @default.
- W2790842545A5011669959 position "0" @default.
- W2790842545A5011669959 rawAffiliation "Conflicts of Interest and Sources of Funding: This work was supported in part by the Memorial Sloan Kettering Cancer Center (MSKCC) NCI core grant [P30 CA008748]. M.J.P. receives support from the MSKCC Mortimer J. Lacher Fellowship supported by the Lymphoma Foundation, the MSK Sawiris Foundation, and the NIH/National Center for Advancing Translational Sciences (UL1TR00457), administered by the Clinical and Translational Science Center at Weill Cornell Medical Center and MSKCC. A.D.G. receives support from the Young Investigator Award from the Conquer Cancer Foundation. A.M.L. is a member of the Parker Institute for Cancer Immunotherapy. A.M.L. also receives support from the MSK Sawiris Foundation and from Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and The Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center.; Disclosures: M.J.P. has no disclosures. A.D.G.: research: ADC Therapeutics, Genentech, Pfizer; From the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Reprints: Alexander M. Lesokhin, MD, 1233 York Ave, New York, NY 10065. E-mail: [email protected].; The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.; consultancy: BMS, Novartis.; consultancy: Celgene. A.M.L.: research: BMS, Novartis, Celgene, Genentech, Merck" @default.